Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

NCT03382834 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tamoxifen
DRUG: Vorinostat
DRUG: Antiretroviral drugs

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)